The rational design of a novel potent analogue of the 5′-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular activity
Authors:
- 1 November 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (22) , 6394-6399
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute
This publication has 23 references indexed in Scilit:
- AMPK inhibition in health and diseaseCritical Reviews in Biochemistry and Molecular Biology, 2010
- A conserved mechanism of autoinhibition for the AMPK kinase domain: ATP-binding site and catalytic loop refolding as a means of regulationActa Crystallographica Section F Structural Biology and Crystallization Communications, 2010
- Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Small Molecule Antagonizes Autoinhibition and Activates AMP-activated Protein Kinase in CellsJournal of Biological Chemistry, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- 5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor MicroenvironmentsMolecular and Cellular Biology, 2006
- Total Syntheses of the Alkaloids Ipalbidinium and Clathryimine BMonatshefte für Chemie - Chemical Monthly, 2003
- Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinaseBiochemical Society Transactions, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- NEW APPLICATIONS OF IMINOPHOSPHORANES. THE PREPARATION OF β-KETO CARBODIIMIDESAND THEIR REARRANGEMENTTO 2-AMINO-1,3-OXAZOLESPhosphorus, Sulfur, and Silicon and the Related Elements, 1991